Copying Kevin Fischbeck's trades since 2013 and holding each position for 1 Year would result in 60.70% of your transactions generating a profit, with an average return of 3.8% per rating.
The most profitable rating made by Kevin Fischbeck
Kevin Fischbeck's Stock Coverage
Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
SCAI
Surgical Care
Dec 16, 2013
Buy
Reiterated
―
2Ratings
―
0.00%
LPNT
LifePoint Health
Apr 28, 2014
Hold
Initiated
―
3Ratings
―
0.00%
BFYT
Benefytt Technologies
Aug 12, 2014
Buy
Reiterated
―
1Ratings
-63.50%
~CIVI
Civitas
Oct 27, 2014
Buy
Initiated
―
1Ratings
+53.80%
HNT
Health Net
Nov 18, 2014
Buy
Assigned
―
3Ratings
+17.83%
~TMH
Team Health Holdings
Jun 20, 2016
Buy
Reiterated
―
3Ratings
-2.40%
ADPTQ
Adeptus Health
Nov 02, 2016
Sell
Downgraded
―
1Ratings
―
0.00%
KND
Kindred Healthcare
Nov 08, 2016
Sell
Reiterated
―
2Ratings
-2.45%
AET
Aetna Inc
Jul 14, 2017
Buy
Reiterated
―
6Ratings
+22.40%
EVHC
Envision Healthcare
Nov 02, 2017
Hold
Downgraded
―
5Ratings
+21.00%
List of latest recommendations made by Kevin Fischbeck. Click to expand and see Kevin Fischbeck's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Kevin Fischbeck activity FAQ
What is the performance of Kevin Fischbeck's recommendations?
The percentage of profitable recommendations made by Kevin Fischbeck is 61%, and the average return per transaction is 3.80%.
What stocks does Kevin Fischbeck cover?
Kevin Fischbeck mostly covers UNH ,HCA ,THC stocks.
What was Kevin Fischbeck's most profitable rating?
Kevin Fischbeck’s most profitable ratings was a buy on SGRY stock on Sep 06, 2019 - Sep 06, 2020. The return on the trade was +203.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here